Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,109 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 35,109 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 29, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.24 | $38.44 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 21 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,955 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 28, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.25 | $38.75 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,924 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 25, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.23 | $38.13 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,893 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 24, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.24 | $38.44 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,862 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 23, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.26 | $39.06 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,831 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 22, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.25 | $38.75 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,800 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 21, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.25 | $38.75 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,769 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 18, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.28 | $39.68 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,738 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 17, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.30 | $40.30 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,707 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 16, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.25 | $38.75 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,676 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 15, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.30 | $40.30 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,645 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 14, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.37 | $42.47 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,614 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 11, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.39 | $43.09 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,583 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 10, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.32 | $40.92 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,552 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 09, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.31 | $40.61 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,521 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 08, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.30 | $40.30 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,490 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 07, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.29 | $39.99 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,459 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 04, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.28 | $39.68 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,428 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 03, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.28 | $39.68 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,397 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 02, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.29 | $39.99 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,366 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 01, 2024 Filed Nov 5, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $1.27 | $39.37 |
DisclosureSEC source: 0001628280-24-045334 · wk-form4_1730842813.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,335 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 30, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 31 | $1.36 | $42.16 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,304 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 27, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 22 | $1.24 | $27.28 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,273 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 26, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.24 | $31.00 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,251 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 25, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 20 | $1.29 | $25.80 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,226 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 24, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 7 | $1.22 | $8.54 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,206 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 23, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.25 | $31.25 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,199 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 20, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.30 | $32.50 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,174 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 19, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.29 | $32.25 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,149 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 18, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.30 | $32.50 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,124 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 17, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.30 | $32.50 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,099 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 16, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.30 | $32.50 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,074 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 13, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.30 | $32.50 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,049 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 12, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.35 | $33.75 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,024 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 11, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 24 | $1.35 | $32.40 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,999 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 10, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $1.30 | $19.50 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,975 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 09, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.33 | $33.25 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,960 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 06, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 6 | $1.30 | $7.80 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,935 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 05, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 23 | $1.28 | $29.44 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,929 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 04, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 23 | $1.35 | $31.05 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,906 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 03, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.38 | $34.50 |
DisclosureSEC source: 0001628280-24-042124 · wk-form4_1727986112.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,883 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 30, 2024 Filed Sep 5, 2024 15:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $1.35 | $17.55 |
DisclosureSEC source: 0001214659-24-016035 · marketforms-66913.xml · nonDerivative · entry 21 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,858 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 30, 2024 Filed Sep 5, 2024 14:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $1.35 | $17.55 |
DisclosureSEC source: 0001214659-24-016075 · marketforms-66913.xml · nonDerivative · entry 21 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,858 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 29, 2024 Filed Sep 5, 2024 15:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.41 | $35.25 |
DisclosureSEC source: 0001214659-24-016035 · marketforms-66913.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,845 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 29, 2024 Filed Sep 5, 2024 14:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.41 | $35.25 |
DisclosureSEC source: 0001214659-24-016075 · marketforms-66913.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,845 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 28, 2024 Filed Sep 5, 2024 15:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.40 | $35.00 |
DisclosureSEC source: 0001214659-24-016035 · marketforms-66913.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,820 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 28, 2024 Filed Sep 5, 2024 14:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.40 | $35.00 |
DisclosureSEC source: 0001214659-24-016075 · marketforms-66913.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,820 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 27, 2024 Filed Sep 5, 2024 15:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $1.40 | $21.00 |
DisclosureSEC source: 0001214659-24-016035 · marketforms-66913.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,795 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 27, 2024 Filed Sep 5, 2024 14:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $1.40 | $21.00 |
DisclosureSEC source: 0001214659-24-016075 · marketforms-66913.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,795 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 26, 2024 Filed Sep 5, 2024 15:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.37 | $34.25 |
DisclosureSEC source: 0001214659-24-016035 · marketforms-66913.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,780 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.